Turns out that Big Pharma’s weight-loss drugs Ozempic and Wegovy can have significant downsides, like stomach paralysis.
Who knew? Bet that didn’t come up in clinical trials.
https://t.co/BZkGn3cNH5— P. D. Mangan Health & Freedom Maximalist 🇺🇸 (@Mangan150) July 26, 2023
Taking a drug for weight loss is like taking a drug for driving too fast.
Like, imagine taking a drug to change a behavior.
Of course it’s going to be unsafe.
A drug designed to treat diabetes has become one of the hottest and most controversial weight loss crazes to date.
Now, people are saying they wished they “never touched it.”
Ozempic is a medication designed for people with Type 2 diabetes that has become widely used as a weight loss drug.
Ozempic and Wegovy are semaglutides, which help the pancreas release the right amount of insulin when blood sugar levels are high.
The Eli Lilly counterpart, Mounjaro, is a tirzepatide that has been shown to help control blood sugar as well.
The drugs work by mimicking a natural hormone, GLP-1, which slows down the passage of food through the stomach, making people feel full for longer.
However, issues start to arise if the drugs slow down the stomach too much.
CNN spoke to several dieters who have been diagnosed with severe gastroparesis, or stomach paralysis, likely as a result of taking Ozempic, their doctors believe.
Gastroparesis is a condition that slows or stops the movement of food from the stomach to the small intestine, according to the National Institutes of Health.
Women are at a higher risk of the condition, and doctors are unable to track down a cause in more than half of cases.
“I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, from Angie, Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.”
Long after she stopped taking the drug, Knight needed stomach bypass surgery, which has since allowed her to eat some of her favorite foods again without throwing them up.
Patients like Knight experienced inexplicable symptoms, such as burps that smelled like sulfur, and sudden bouts of vomiting so severe it landed them in the hospital — including some who had already been off the drug for months before illness arose.
Endoscopies would show their stomachs full of days-old food, which is unusual since typically less than 10% of food consumed is left in the stomach four hours after a meal.
Doctors have said they’re seeing a lot of cases similar to Knight’s and others who spoke to CNN, as well as a spike in ER admissions, all involving GLP-1 class drugs.
The Food and Drug Administration also confirmed such reports, though they are unable to officially determine whether these cases of gastroparesis were caused by the weight-loss drugs or by another condition.
“The FDA has received reports of gastroparesis with semaglutide and liraglutide, some of which documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said in a statement to CNN.
Obesity is not a disease.
It’s a behavior.
These drugs are going to end up being like those drugs that caused people to be born without limbs.
Like, it was totally insane to put these on the market.
America is both communist and libertarian.
Imagine it.
Super high taxes – crippling taxes – and no regulation on corporations.
It’s like wow.
Pick one, huh?